X
  • No products in the list

M-BCR-ABL1 PCR Kit

Short description

The Imegen M-BCR-ABL1 (IMG-121) detection kit stands out as an advanced tool in molecular biology, offering optimal amplification and quantification of M-BCR-ABL1 (p210) rearrangement. It is designed to detect minimal residual disease (MRD), offering robust sensitivity and significant advancements in total RNA extraction protocols and reverse transcription methodologies.

The detection kit allows precise calculation of the number of copies of rearrangements and endogenous ABL genes, enhancing our understanding of diseases like chronic myeloid leukemia (CML).

Product highlights

  • Detecting the number of copies of the M-BCR-ABL1 rearrangement (p210), and the number of copies of the endogenous ABL1 gene
  • The detection limit for both ABL1 and M-BCR-ABL1 (p210) has been established at 5 total copies
  • It includes a standardized calibrator for the determination of the normalized copy number of M-BCR-ABL1: the pIMEGEN vector (M-BCR-ABL1:ABL1 in a 1:1 copy ratio) calibrated from the IRMM Reference Material [ERM -AD623])

Ask for a quote

M-BCR-ABL1 PCR Kit

More
information

Downloads

Instructions for Use

MSDS M-BCR-ABL kit

 

For any missing information or if you require additional details, please do not hesitate to contact us. 

Specifications of the M-BCR-ABL1 PCR Kit

Understanding the Functionality of the Detection Kit

The Imegen M-BCR-ABL1 (IMG-121) detection kit employs a combination of oligonucleotides and hydrolysis probes for the efficient amplification and quantification of M-BCR-ABL1 (p210) rearrangement. This real-time PCR tool is designed to enable lab scientists to calculate the number of copies of the rearrangement and the number of copies of the endogenous ABL gene. Furthermore, this genetic analysis allows the detection of minimal residual disease (MRD), with the sensitivity level contingent on the maximum number of detectable copies of the ABL1 reference gene.

To achieve the necessary sensitivity limit for MRD analysis that would result in a clinically significant molecular response, the process of total RNA extraction from peripheral blood or bone marrow cells needs to be optimized. Consequently, the reverse transcription protocols should be maximized to yield the greatest amount of complementary DNA (cDNA) in each sample.

The detection kit uses the standardized calibrator available at the Institute of Reference Materials and Measurements (IRMM), Belgium, catalog number ERM-AD623, for calibrating the pIMEGEN plasmid (M-BCR-ABL1:ABL1 at a copy ratio of 1:1). This plasmid is used as a standard for the quantification performed with the kit.

The kit is intended for in vitro diagnostic use and is specifically designed for professionals in the molecular biology sector.

Advantages of the Imegen M-BCR-ABL1 (IMG-121) Detection Kit

– Utilizes a combination of oligonucleotides and hydrolysis probes for efficient amplification and quantification of M-BCR-ABL1 (p210) rearrangement.
– Enables precise calculation of the number of copies of the rearrangement and the endogenous ABL gene.
– Allows detection of minimal residual disease (MRD), with sensitivity dependent on the maximum detectable copies of the ABL1 reference gene.
– Facilitates optimization of total RNA extraction process from peripheral blood or bone marrow cells, enhancing the reverse transcription protocols and maximizing the quantity of cDNA in each sample.
– Uses the standardized calibrator from the Institute of Reference Materials and Measurements (IRMM), ensuring reliable quantification results.

 

 

Components of the M-BCR-ABL1 PCR Kit

The kit contains the following reagents required to perform 48 real-time PCR reactions for each of the two targets analyzed in this assay:

  • BCR Screening Master Mix: specific oligonucleotides and hydrolysis probe (FAMTM) that simultaneously detect the M-BCR-ABL1 y m-BCR-ABL1 rearrangements.
  • ABL1 Master Mix: Specific oligonucleotides and hydrolysis probe (FAMTM) that detect the reference gene ABL1.
  • Positive Control: Positive control of a BCR-ABL1 transcript and ABL1

Explore Related Items